6.
Miyauchi J, Kelleher C, Yang Y, Wong G, Clark S, Minden M
. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood. 1987; 70(3):657-63.
View
7.
Benko I, Kovacs P, Szegedi I, MEGYERI A, Kiss A, Balogh E
. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. Naunyn Schmiedebergs Arch Pharmacol. 2001; 363(5):499-508.
DOI: 10.1007/s002100000390.
View
8.
Santavenere E, Di Pietro R, Centurione M, Di Domenicantonio L, Trubiani O, Rana R
. Synergistic regulatory effects of TNF alpha, IL-1 alpha and IFN alpha on the growth and differentiation of Daudi lymphoma cells. Cell Biol Int. 1996; 20(5):335-8.
DOI: 10.1006/cbir.1996.0037.
View
9.
Mikala G, Xie J, BERENCSI G, Kiss C, Marton I, Domjan G
. Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res. 1999; 5(1):73-9.
DOI: 10.1053/paor.1999.0073.
View
10.
McSweeney E, Giles F, Worman C, Jewel A, Tsakona C, Hoffbrand A
. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia. Br J Haematol. 1993; 85(1):77-83.
DOI: 10.1111/j.1365-2141.1993.tb08648.x.
View
11.
Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D
. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996; 2(3):342-6.
DOI: 10.1038/nm0396-342.
View
12.
Pogue S, Preston B, Stalder J, Bebbington C, Cardarelli P
. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J Interferon Cytokine Res. 2004; 24(2):131-9.
DOI: 10.1089/107999004322813372.
View
13.
Jewell A
. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1996; 21(1-2):43-7.
DOI: 10.3109/10428199609067578.
View
14.
Zimring J, Goodbourn S, Offermann M
. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol. 1998; 72(1):701-7.
PMC: 109425.
DOI: 10.1128/JVI.72.1.701-707.1998.
View
15.
Balmelli C, Vincent I, Rau H, Guzylack-Piriou L, McCullough K, Summerfield A
. Fc gamma RII-dependent sensitisation of natural interferon-producing cells for viral infection and interferon-alpha responses. Eur J Immunol. 2005; 35(8):2406-15.
DOI: 10.1002/eji.200525998.
View
16.
Sarmay G, Koncz G, Gergely J
. Human type II Fcgamma receptors inhibit B cell activation by interacting with the p21(ras)-dependent pathway. J Biol Chem. 1996; 271(48):30499-504.
DOI: 10.1074/jbc.271.48.30499.
View
17.
Kiss C
. Interferons in pediatric oncology: end of the beginning or beginning of the end?. Med Pediatr Oncol. 1998; 30(6):364-6.
DOI: 10.1002/(sici)1096-911x(199806)30:6<364::aid-mpo12>3.0.co;2-i.
View
18.
Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S
. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol. 1996; 157(7):2939-46.
View
19.
Picchio G, Sabbe R, Gulizia R, McGrath M, Herndier B, Mosier D
. The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology. 1997; 238(1):22-9.
DOI: 10.1006/viro.1997.8822.
View